Leptin treatment has no effect on type 2 diabetes, study finds

05/17/2011 | DoctorsLounge.com

Short-term leptin treatment did not show any significant improvements on skeletal muscle, liver and adipose tissue insulin sensitivity in obese patients recently diagnosed with type 2 diabetes, experts reported in the journal Diabetes. According to the results, leptin did not fare better in reducing blood glucose, glycerol and palmitate levels in high-risk patients when compared with a placebo.

View Full Article in:

DoctorsLounge.com

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Consultant
Attest Health Care Advisors
Nationwide, SL_Nationwide
NGS Provider Enrollment Rep
National Government Services - WellPoint
Harrisburg, PA
Consultant
Attest Health Care Advisors
Nationwide, SL_Nationwide
Program Manager II
Tufts Health Plan/Network Health
Medford, MA
Director, Medicare Advantage/Medicare Part D Focus
Avalere Health
Washington, DC